Finally, further studies in somatic tissue of serrated lesions or CRC in WNK2 carriers could shed light regarding mutational signatures associated with this genetic defect, as well as organoid modelling could also help to confirm the involvement of this gene in the sequence of events moving towards a serrated phenotype. This evidence concerns the gene WNK2 and colorectal carcinoma.